首页> 美国卫生研究院文献>PLoS Pathogens >ATRX restricts Human Cytomegalovirus (HCMV) viral DNA replication through heterochromatinization and minimizes unpackaged viral genomes
【2h】

ATRX restricts Human Cytomegalovirus (HCMV) viral DNA replication through heterochromatinization and minimizes unpackaged viral genomes

机译:ATRX 通过异染色质化限制人巨细胞病毒 (HCMV) 病毒 DNA 复制并最大限度地减少未包装的病毒基因组

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ATRX limits the accumulation of human cytomegalovirus (HCMV) Immediate Early (IE) proteins at the start of productive, lytic infections, and thus is a part of the cell-intrinsic defenses against infecting viruses. ATRX is a chromatin remodeler and a component of a histone chaperone complex. Therefore, we hypothesized ATRX would inhibit the transcription of HCMV IE genes by increasing viral genome heterochromatinization and decreasing its accessibility. To test this hypothesis, we quantitated viral transcription and genome structure in cells replete with or depleted of ATRX. We found ATRX did indeed limit viral IE transcription, increase viral genome chromatinization, and decrease viral genome accessibility. The inhibitory effects of ATRX extended to Early (E) and Late (L) viral protein accumulation, viral DNA replication, and progeny virion output. However, we found the negative effects of ATRX on HCMV viral DNA replication were independent of its effects on viral IE and E protein accumulation but correlated with viral genome heterochromatinization. Interestingly, the increased number of viral genomes synthesized in ATRX-depleted cells were not efficiently packaged, indicating the ATRX-mediated restriction to HCMV viral DNA replication may benefit productive infection by increasing viral fitness. Our work mechanistically describes the antiviral function of ATRX and introduces a novel, pro-viral role for this protein, perhaps explaining why, unlike during infections with other herpesviruses, it is not directly targeted by a viral countermeasure in HCMV infected cells.
机译:ATRX 在生产性裂解性感染开始时限制了人巨细胞病毒 (HCMV) 即刻早期 (IE) 蛋白的积累,因此是细胞对感染病毒的内在防御的一部分。ATRX 是一种染色质重塑剂,是组蛋白伴侣复合物的组成部分。因此,我们假设 ATRX 会通过增加病毒基因组异染色质化和降低其可及性来抑制 HCMV IE 基因的转录。为了检验这一假设,我们定量了充满或耗尽 ATRX 的细胞中的病毒转录和基因组结构。我们发现 ATRX 确实限制了病毒 IE 转录,增加了病毒基因组染色质化,并降低了病毒基因组的可及性。ATRX 的抑制作用延伸到早期 (E) 和晚期 (L) 病毒蛋白积累、病毒 DNA 复制和后代病毒粒子输出。然而,我们发现 ATRX 对 HCMV 病毒 DNA 复制的负面影响与其对病毒 IE 和 E 蛋白积累的影响无关,但与病毒基因组异染色质化相关。有趣的是,在 ATRX 耗尽的细胞中合成的病毒基因组数量增加没有被有效包装,这表明 ATRX 介导的对 HCMV 病毒 DNA 复制的限制可能通过增加病毒适应性来有益于生产性感染。我们的工作从机制上描述了 ATRX 的抗病毒功能,并介绍了这种蛋白质的新颖的促病毒作用,这也许可以解释为什么与其他疱疹病毒感染期间不同,它不是 HCMV 感染细胞中病毒对策的直接目标。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号